What This Immunome Sale Signals Ahead of FDA Milestone
When a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
Explore various ways to get quick cash today. These strategies will help you access funds when you need them most.
23,336 articlesWhen a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
PureCycle (PCT) is expanding its recycling footprint, and the Q4 2025 earnings call could reshape how investors value...
Oil markets are in flux, and Occidental faces a pivotal year. This guide breaks down what to expect from occidental (...
VanEck’s Gaming ETF has retooled into a Digital Native Economy ETF, raising doubts about whether its income story can...
Kymera’s CEO recently monetized a sizable stake after a strong run. This article unpacks the insider sale, what kymer...
As Agora releases Q4 2025 data, investors will watch API growth, customer momentum, and profitability signals. This g...
As streaming shifts accelerate, FuboTV's 2026 earnings outlook hinges on subscriber growth, ad revenue, and content c...
A decade of reinvested dividends can turn a modest $1,000 investment in Chevron into a much larger nest egg, even as ...
Kohl's stock moved in dramatic strides after its latest earnings report, tumbling early before a sharp rally. This ar...
Gladstone Investment faces a quarterly miss that pressures its 5.7% yield, spotlighting the risks and resilience of a...
When Insperity s top executive buys a sizable stake, investors sit up. This article breaks down what insperity stock ...
February delivered a sharp move for Iren Limited as the market wrestled with a bold pivot from neocloud mining to AI ...